insights_auto
Why is EDIT up 13,46%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
2,95 US$
arrow_upward
+13,46%(+0,35) 1D
2,86 US$
arrow_downward
-2,99% (-0,088)bedtimeAfter hours
Closed: 28 ოქტ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
2,59 US$
High
2,96 US$
Low
2,54 US$
Mkt. cap
453,06 მლნ.
Avg. vol.
2,91 მლნ.
Volume
0,00
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
Open
2,59 US$
High
2,96 US$
Low
2,54 US$
Mkt. cap
453,06 მლნ.
Avg. vol.
2,91 მლნ.
Volume
0,00
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,74 US$
Beta
2,00
Shares outstanding
153,58 მლნ.
No. of employees
87
News stories
From web sources and news partners
The Business Journals
·
25 წუთის წინ
Energy software company Stem Inc. considers sale in strategic review after NYSE warning
Bitcoin Foundation
·
15 წუთის წინ
JQQQ Tokenized Nasdaq-100 Fund Launches on Stellar
TradingView
·
1 საათის წინ
Stock Market: Will S&P 500 Open Up or Down Today?
Reuters
·
4 საათის წინ
Asian shares wobble as Alphabet earnings miss drags Wall St futures lower
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc